Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2021 Earnings and Company Updates
29 April 2021 - 9:30PM
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing
company focused on developing curative therapeutics using
CRISPR/Cas9 technology both in vivo and ex vivo, will present its
first quarter 2021 financial results and operational highlights in
a conference call on May 6 at 8 a.m. E.T.
To join the call:
- U.S. callers should dial 1-833-316-0545 and international
callers should dial 1-412-317-5726, approximately five minutes
before the call.
- All participants should ask to be connected to the Intellia
Therapeutics conference call.
A replay of the call will be available through the Events and
Presentations page of the Investors & Media section of the
company’s website at www.intelliatx.com, beginning on May 6 at 12
p.m. E.T.
About Intellia TherapeuticsIntellia
Therapeutics is a leading clinical-stage genome editing
company, focused on the development of proprietary, potentially
curative therapeutics using the CRISPR/Cas9 system. Intellia
believes the CRISPR/Cas9 technology has the potential to transform
medicine by both producing therapeutics that permanently edit
and/or correct disease-associated genes in the human body with a
single administration, and creating enhanced engineered cells that
can treat oncological and immunological diseases. Intellia’s
combination of deep scientific, technical and clinical development
experience, along with its leading intellectual property portfolio,
puts it in a unique position to unlock broad therapeutic
applications of the CRISPR/Cas9 technology and create new classes
of therapeutic products. Learn more about Intellia and
CRISPR/Cas9 at intelliatx.com. Follow us on Twitter
@intelliatweets.
Intellia Contacts:
Investors:Lina LiDirectorInvestor
Relations+1-857-706-1612lina.li@intelliatx.com
Media:Julie FergusonInterim Head of External
Affairs &
Communications+1-312-385-0098julie.ferguson@intelliatx.com
Intellia Therapeutics (NASDAQ:NTLA)
Historical Stock Chart
From Apr 2024 to May 2024
Intellia Therapeutics (NASDAQ:NTLA)
Historical Stock Chart
From May 2023 to May 2024